Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ROS-mediated apoptosis in HT-1080 cells

Tsui-Chin Huang1, Jheng-Fong Lee1, Jyh-Yih Chen1

  • 1Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, 23-10 Dahuen Rd., Jiaushi, Ilan 262, Taiwan.

Marine Drugs
|November 11, 2011
PubMed

Insights

Pardaxin, an antimicrobial peptide, shows potential as an anticancer agent by inducing apoptosis in human fibrosarcoma cells. This peptide selectively triggers programmed cell death, offering a novel approach for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Antimicrobial peptides (AMPs) are being explored for therapeutic applications.
  • Pardaxin, isolated from the Red Sea Moses sole, is an AMP with unknown anticancer properties.
  • Apoptosis induction is a key mechanism in cancer prevention.

Purpose of the Study:

  • To investigate the antitumor activity of pardaxin against human fibrosarcoma HT-1080 cells.
  • To determine if pardaxin induces apoptosis and explore the underlying mechanisms.
  • To evaluate pardaxin's potential as a novel anticancer agent.

Main Methods:

  • Cell proliferation assays were performed on HT-1080 cells treated with pardaxin.
  • Apoptosis was assessed by measuring phosphatidylserine externalization and chromatin condensation.
  • Caspase-3/7 activities, mitochondrial membrane potential, and reactive oxygen species (ROS) production were analyzed.

Main Results:

  • Pardaxin significantly inhibited HT-1080 cell proliferation by inducing apoptosis.
  • Apoptosis was evidenced by increased phosphatidylserine externalization and chromatin condensation.
  • Pardaxin elevated caspase-3/7 activities, disrupted mitochondrial membrane potential, and increased ROS production, which were crucial for its effects.

Conclusions:

  • Pardaxin exhibits significant antitumor activity against human fibrosarcoma cells.
  • The mechanism involves pardaxin-induced apoptosis, mediated by caspase-3/7 activation and ROS generation.
  • Pardaxin represents a promising candidate for developing targeted cancer therapies.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...